40 related articles for article (PubMed ID: 38677560)
1. Benzopyran hydrazones with dual PPARα/γ or PPARα/δ agonism and an anti-inflammatory effect on human THP-1 macrophages.
García A; Vila L; Duplan I; Schiel MA; Enriz RD; Hennuyer N; Staels B; Cabedo N; Cortes D
Eur J Med Chem; 2024 Feb; 265():116125. PubMed ID: 38185055
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory effects and improved metabolic derangements in ob/ob mice by a newly synthesized prenylated benzopyran with pan-PPAR activity.
Marques P; Villarroel-Vicente C; Collado A; García A; Vila L; Duplan I; Hennuyer N; Garibotto F; Enriz RD; Dacquet C; Staels B; Piqueras L; Cortes D; Sanz MJ; Cabedo N
Pharmacol Res; 2023 Jan; 187():106638. PubMed ID: 36586645
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological studies of "Polycerasoidol" and "trans-δ-Tocotrienolic acid" derivatives as PPARα and/or PPARγ agonists.
Vila L; Cabedo N; Villarroel-Vicente C; García A; Bernabeu Á; Hennuyer N; Staels B; Franck X; Figadère B; Sanz MJ; Cortes D
Bioorg Med Chem; 2022 Jan; 53():116532. PubMed ID: 34863066
[TBL] [Abstract][Full Text] [Related]
4. Polycerasoidol, a Natural Prenylated Benzopyran with a Dual PPARα/PPARγ Agonist Activity and Anti-inflammatory Effect.
Bermejo A; Collado A; Barrachina I; Marqués P; El Aouad N; Franck X; Garibotto F; Dacquet C; Caignard DH; Suvire FD; Enriz RD; Piqueras L; Figadère B; Sanz MJ; Cabedo N; Cortes D
J Nat Prod; 2019 Jul; 82(7):1802-1812. PubMed ID: 31268307
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of a new 2-prenylated quinoline as potential drug for metabolic syndrome with pan-PPAR activity and anti-inflammatory effects.
Villarroel-Vicente C; García A; Zibar K; Schiel MA; Ferri J; Hennuyer N; Enriz RD; Staels B; Cortes D; Cabedo N
Bioorg Med Chem Lett; 2024 Jul; 106():129770. PubMed ID: 38677560
[TBL] [Abstract][Full Text] [Related]
7. Natural products and analogs as preventive agents for metabolic syndrome via peroxisome proliferator-activated receptors: An overview.
Villarroel-Vicente C; Gutiérrez-Palomo S; Ferri J; Cortes D; Cabedo N
Eur J Med Chem; 2021 Oct; 221():113535. PubMed ID: 33992930
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus.
Jay MA; Ren J
Curr Diabetes Rev; 2007 Feb; 3(1):33-9. PubMed ID: 18220654
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.
Aleshin S; Strokin M; Sergeeva M; Reiser G
Neurochem Int; 2013 Oct; 63(4):322-30. PubMed ID: 23811400
[TBL] [Abstract][Full Text] [Related]
10. The roles of peroxisome proliferator-activated receptors in the metabolic syndrome.
Mansour M
Prog Mol Biol Transl Sci; 2014; 121():217-66. PubMed ID: 24373239
[TBL] [Abstract][Full Text] [Related]
11. Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
Tenenbaum A; Fisman EZ
Cardiovasc Diabetol; 2012 Nov; 11():140. PubMed ID: 23150952
[TBL] [Abstract][Full Text] [Related]
12. Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons.
Tenenbaum A; Motro M; Fisman EZ
Cardiovasc Diabetol; 2005 Sep; 4():14. PubMed ID: 16168052
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
